36C25626Q1277.pdf

PAGE 1 OF1. REQUISITION NO.

2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE 4. ORDER NO. 5. SOLICITATION NUMBER 6. SOLICITATION ISSUE DATE

a. NAME b. TELEPHONE NO. (No Collect Calls) 8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY CODE 10. THIS ACQUISITION IS UNRESTRICTED OR SET ASIDE: % FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ IFB RFP

15. DELIVER TO CODE 16. ADMINISTERED BY CODE

17a. CONTRACTOR/OFFEROR CODE FACILITY CODE 18a. PAYMENT WILL BE MADE BY CODE

TELEPHONE NO. UEI: EFT:

PHONE: FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19. 20. 21. 22. 23. 24.

ITEM NO. SCHEDULE OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA 26. TOTAL AWARD AMOUNT (For Govt. Use Only)

27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA ARE ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA ARE ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________ 29. AWARD OF CONTRACT: REF. ___________________________________ OFFER COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND DATED ________________________________. YOUR OFFER ON SOLICITATION DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)

30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION (REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

36C25626Q1277 08-25-2026

William Shaver 601-362-4471 08-31-2026

07:00 CDT

36C256 Department of Veterans Affairs Network Contracting Office 16

715 South Pear Orchard Road Ridgeland MS 39157

X

325413

1250 Employees

N/A

X

36C586

Department of Veterans Affairs G.V. (Sonny) Montgomery VAMC

1500 E. Woodrow Wilson Drive Jackson MS 39216-5199

10N16

Department of Veterans Affairs Network Contracting Office 16

715 South Pear Orchard Road Ridgeland MS 39157

FSC e-Invoice Payment http://www.fsc.va.gov/fsc/einvoice.asp Invoice Setup Information 1-877-489-6135 invoice must be submitted electronically

1-877-489-6135

See CONTINUATION Page

This is a solicitation for commercial supplies prepared in accordance with the format in RFO FAR 12.2, as supplemented with additional information included in this notice.

See Price/Cost Schedule, Statement of Work, Addendum to FAR 52.212-1 Instructions to Offerors-Commercial Products and Commercial Services, and 52.212-2 Evaluation-Commercial Products and Commercial Services.

Submit all question to William.Shaver@va.gov. All questions must be submitted by 08/26/2026, at 15:00 CDT.

Due to the urgency of this requirement, time extensions will not be provided.

See CONTINUATION Page

X X

X 1(One)

36C25626Q1277

Table of Contents

SECTION A

A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

B.1 PRICE/COST SCHEDULE

ITEM INFORMATION

B.2 DELIVERY SCHEDULE

B.3 STATEMENT OF WORK

SECTION C - CONTRACT CLAUSES

C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES (OCT 2025) (DEVIATION)

C.2 52.217-8 OPTION TO EXTEND SERVICES (NOV 1999)

C.3 52.217-9 OPTION TO EXTEND THE TERM OF THE CONTRACT (MAR 2000) ...31

C.4 52.222-90 ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS

(DEVIATION APR 2026)

C.5 52.223-23 SUSTAINABLE PRODUCTS (NOV 2025) (DEVIATION)

C.6 52.240-91 SECURITY PROHIBITIONS AND EXCLUSIONS (NOV 2025)

(DEVIATION)

C.7 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS

SECTION E - SOLICITATION PROVISIONS

E.1 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (OCT 2025) (DEVIATION)

E.2 ADDENDUM to FAR 52.212-1 INSTRUCTIONS TO OFFERORS- COMMERCIAL PRODUCTS and COMMERCIAL SERVICES

E.3 52.216-1 TYPE OF CONTRACT (NOV 2025) (DEVIATION)

E.4 52.225-4 BUY AMERICAN—FREE TRADE AGREEMENTS—ISRAELI TRADE

ACT CERTIFICATE (DEVIATION) (NOV 2025) ALTERNATE II (JAN 2025)

E.5 52.240-90 SECURITY PROHIBITIONS AND EXCLUSIONS REPRESENTATIONS

AND CERTIFICATIONS (NOV 2025) (DEVIATION)

E.6 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB

1998)

E.7 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL

SERVICES (NOV 2021)

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR: POC Name:_________________ Address: ___________________ Phone: _____________________ Email: ______________________ DUNS Number: ______________ Tax ID Number: ______________

b. GOVERNMENT: William Shaver, Contract Specialist

Department of Veterans Affairs Network Contracting Office 16 715 South Pear Orchard Road Ridgeland MS 39157 E-mail: William.Shaver@va.gov

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

[X] 52.232-33, Payment by Electronic Funds Transfer—System For Award Management, or

[] 52.232-36, Payment by Third Party

3. INVOICES: Invoices shall be submitted in arrears:

a. Quarterly []

b. Semi-Annually []

c. Other [x] After acceptance of all items.

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.

Invoicing shall be in accordance with the requirements of The Department of Veterans Affairs (VA) Financial Services Center (VAFSC). The latest information shall be used for invoicing and payments and may change during the Period of Performance of this acquisition. Current Invoicing information is located at http://www.fsc.va.gov/einvoice.asp

5. SECURE FAX: Please review VA Handbook 6500 that requires the following statement on all fax cover sheets be included:

This fax is intended only for the use of the person or office to which it is addressed and may contain information that is privileged, confidential, or protected by law. All others are hereby notified that the receipt of this fax does not waive any applicable privilege or exemption for disclosure and that any dissemination, distribution, or copying of this communication is prohibited. If you have received this fax in error, please notify this office immediately at the telephone number listed above.

6. Mandatory written disclosures required by FAR clause 52.203-13 to the Department of Veterans Affairs, Office of Inspector General (OIG) must be made electronically through the VA OIG Hotline at https://www.va.gov/oig/hotline/ and clicking on "FAR clause 52.203-13 Reporting." If you experience difficulty accessing the website, call the Hotline at 1-800-488-8244 for further instructions.

7. The Contracting Officer will issue a post award orientation letter (in lieu of a conference) for contract orientation purposes in accordance with FAR 42.504.

8. ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

AMENDMENT NO DATE

(End of B.1 Contract Administration Information)

B.1 PRICE/COST SCHEDULE

ITEM INFORMATION

ITEM

NUMBER

DESCRIPTION OF

SUPPLIES/SERVIC

ES QUANTITY UNIT UNIT PRICE AMOUNT

0001 26.00 EA _____________

ALBACYTE A1 CELLS, 1X10ML in accordance with Statement of Work.

Contract Period: Base POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 1

0002 28.00 EA _____________

ALBACYTE A2 CELLS 1X10ML in accordance with Statement of Work.

Contract Period: Base POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 2

0003 26.00 EA _____________

ALBACYTE B CELLS, 1X10ML in accordance with Statement of Work.

Contract Period: Base POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 3

0004 28.00 EA _____________

ALBACYTE ANTIBODY SCREEN (3 CELLS), 3X10ML SETS

EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Base POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 4

0005 13.00 EA _____________

ALBACYTE ID PANEL ALPHA-10-CELL ANTIBODY ID,

10X5ML 1SET EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Base POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 5

0006 52.00 EA _____________

ALBACYTE IgG SENSITIZED CELLS, 1Z10ML EACH EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Base POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic

Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 6

0007 28.00 EA _____________

ALBACYTE C3 COATED RED BLOOD CELLS, 1X3ML EVERY

4 WEEKS in accordance with Statement of Work.

Contract Period: Base POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 7

0008 13.00 EA _____________

ALBASURE QC KIT, 4X10ML SET EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Base POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 8

1001 26.00 EA _____________

ALBACYTE A1 CELLS, 1X10ML in accordance with Statement of Work.

Contract Period: Option 2 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 1

1002 28.00 EA _____________

ALBACYTE A2 CELLS 1X10ML in accordance with Statement of Work.

Contract Period: Option 1 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 2

1003 26.00 EA _____________

ALBACYTE B CELLS, 1X10ML in accordance with Statement of Work.

Contract Period: Option 1 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 3

1004 28.00 EA _____________

ALBACYTE ANTIBODY SCREEN (3 CELLS), 3X10ML SETS

EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 1 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 4

1005 13.00 EA _____________

ALBACYTE ID PANEL ALPHA-10-CELL ANTIBODY ID,

10X5ML 1SET EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 1 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

LOCAL STOCK NUMBER: 5

1006 52.00 EA _____________

ALBACYTE IgG SENSITIZED CELLS, 1Z10ML EACH EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 1 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 6

1007 28.00 EA _____________

ALBACYTE C3 COATED RED BLOOD CELLS, 1X3ML EVERY

4 WEEKS in accordance with Statement of Work.

Contract Period: Option 1 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 7

1008 13.00 EA _____________

ALBASURE QC KIT, 4X10ML SET EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 1 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 8

2001 26.00 EA _____________

ALBACYTE A1 CELLS, 1X10ML in accordance with Statement of Work.

Contract Period: Option 2 POP Begin: 10-01-2028

POP End: 09-30-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 1

2002 28.00 EA _____________

ALBACYTE A2 CELLS 1X10ML in accordance with Statement of Work.

Contract Period: Option 2 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 2

2003 26.00 EA _____________

ALBACYTE B CELLS, 1X10ML in accordance with Statement of Work.

Contract Period: Option 2 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 3

2004 28.00 EA _____________

ALBACYTE ANTIBODY SCREEN (3 CELLS), 3X10ML SETS

EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 2 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 4

2005 13.00 EA _____________ _____________

ALBACYTE ID PANEL ALPHA-10-CELL ANTIBODY ID,

10X5ML 1SET EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 2 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 5

2006 52.00 EA _____________

ALBACYTE IgG SENSITIZED CELLS, 1Z10ML EACH EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 2 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 6

2007 28.00 EA _____________

ALBACYTE C3 COATED RED BLOOD CELLS, 1X3ML EVERY

4 WEEKS in accordance with Statement of Work.

Contract Period: Option 2 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 7

2008 13.00 EA _____________

ALBASURE QC KIT, 4X10ML SET EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 2 POP Begin: 10-01-2028 POP End: 09-30-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 8

3001 26.00 EA _____________

ALBACYTE A1 CELLS, 1X10ML in accordance with Statement of Work.

Contract Period: Option 3 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 1

3002 28.00 EA _____________

ALBACYTE A2 CELLS 1X10ML in accordance with Statement of Work.

Contract Period: Option 3 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 2

3003 26.00 EA _____________

ALBACYTE B CELLS, 1X10ML in accordance with Statement of Work.

Contract Period: Option 3 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 3

3004 28.00 EA _____________

ALBACYTE ANTIBODY SCREEN (3 CELLS), 3X10ML SETS

EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 3 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 4

3005 13.00 EA _____________

ALBACYTE ID PANEL ALPHA-10-CELL ANTIBODY ID,

10X5ML 1SET EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 3 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 5

3006 52.00 EA _____________

ALBACYTE IgG SENSITIZED CELLS, 1Z10ML EACH EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 3 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 6

3007 28.00 EA _____________

ALBACYTE C3 COATED RED BLOOD CELLS, 1X3ML EVERY

4 WEEKS in accordance with Statement of Work.

Contract Period: Option 3 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic

LOCAL STOCK NUMBER: 7

3008 13.00 EA _____________

ALBASURE QC KIT, 4X10ML SET EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 3 POP Begin: 10-01-2029 POP End: 09-30-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 8

4001 26.00 EA _____________

ALBACYTE A1 CELLS, 1X10ML in accordance with Statement of Work.

Contract Period: Option 4 POP Begin: 10-01-2030 POP End: 09-30-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 1

4002 28.00 EA _____________

ALBACYTE A2 CELLS 1X10ML in accordance with Statement of Work.

Contract Period: Option 4 POP Begin: 10-01-2030 POP End: 09-30-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 2

4003 26.00 EA _____________

ALBACYTE B CELLS, 1X10ML in accordance with Statement of Work.

Contract Period: Option 4 POP Begin: 10-01-2030 POP End: 09-30-2031

PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 3

4004 28.00 EA _____________

ALBACYTE ANTIBODY SCREEN (3 CELLS), 3X10ML SETS

EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 4 POP Begin: 10-01-2030 POP End: 09-30-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 4

4005 13.00 EA _____________

ALBACYTE ID PANEL ALPHA-10-CELL ANTIBODY ID,

10X5ML 1SET EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 4 POP Begin: 10-02-2030 POP End: 09-30-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 5

4006 52.00 EA _____________

ALBACYTE IgG SENSITIZED CELLS, 1Z10ML EACH EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 4 POP Begin: 10-01-2030 POP End: 09-30-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 6

4007 28.00 EA _____________ _____________

ALBACYTE C3 COATED RED BLOOD CELLS, 1X3ML EVERY

4 WEEKS in accordance with Statement of Work.

Contract Period: Option 4 POP Begin: 10-31-2030 POP End: 09-30-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 7

4008 13.00 EA _____________

ALBASURE QC KIT, 4X10ML SET EVERY 4 WEEKS in accordance with Statement of Work.

Contract Period: Option 4 POP Begin: 10-01-2030 POP End: 09-30-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

LOCAL STOCK NUMBER: 8

GRAND TOTAL _____________

B.2 DELIVERY SCHEDULE

ITEM

NUMBER SHIPPING INFORMATION

QUANTIT

Y

DELIVERY

DATE

0001 26.00 See Price/Cost Schedule

0002 28.00 See Price/Cost Schedule

0003 26.00 See Price/Cost Schedule

0004 28.00 See Price/Cost Schedule

0005 13.00 See Price/Cost Schedule

0006 52.00 See Price/Cost Schedule

0007 28.00 See Price/Cost Schedule

0008 13.00 See Price/Cost Schedule

1001 26.00 See Price/Cost Schedule

1002 28.00 See Price/Cost Schedule

1003 26.00 See Price/Cost Schedule

1004 28.00 See Price/Cost Schedule

1005 13.00 See Price/Cost Schedule

1006 52.00 See Price/Cost Schedule

1007 28.00 See Price/Cost Schedule

1008 13.00 See Price/Cost Schedule

2001 26.00 See Price/Cost Schedule

2002 28.00 See Price/Cost Schedule

2003 26.00 See Price/Cost Schedule

2004 28.00 See Price/Cost

2005 13.00 See Price/Cost Schedule

2006 52.00 See Price/Cost Schedule

2007 28.00 See Price/Cost Schedule

2008 13.00 See Price/Cost Schedule

3001 26.00 See Price/Cost Schedule

3002 28.00 See Price/Cost Schedule

3003 26.00 See Price/Cost Schedule

3004 28.00 See Price/Cost Schedule

3005 13.00 See Price/Cost Schedule

3006 52.00 See Price/Cost Schedule

3007 28.00 See Price/Cost Schedule

3008 13.00 See Price/Cost Schedule

4001 26.00 See Price/Cost Schedule

4002 28.00 See Price/Cost Schedule

4003 26.00 See Price/Cost Schedule

4004 28.00 See Price/Cost

4005 13.00 See Price/Cost Schedule

4006 52.00 See Price/Cost Schedule

4007 28.00 See Price/Cost Schedule

4008 13.00 See Price/Cost Schedule

B.3 STATEMENT OF WORK

Department of Veterans Affairs Pathology & Laboratory Medicine Service (P&LMS)

G.V(Sonny) Montgomery VAMC 1500 E Woodrow Wilson Av Jackson MS 39216

Alba Brand — Tube Blood Bank Reagents (Brand‑Name Only; No Substitutions)

1. PURPOSE

Provide Alba Brand tube‑method blood bank reagents in support of transfusion medicine testing (type and screen, antibody identification, crossmatches) at G.V. (Sonny) Montgomery VAMC.

This requirement is BRAND‑NAME ONLY to ensure continuity with the facility’s validated backup/supplemental tube method and associated SOPs. No “or equal” products or substitutions are permitted. Physicians rely on the accuracy and timeliness of these tests to administer potentially lifesaving treatments through blood and other blood products.

2. BRAND-NAME ONLY REQUIREMENT

This acquisition is restricted to Alba brand reagents. No equivalent or alternate products will be accepted. The restriction is necessary to:

1. Maintain continuity with the laboratory’s validated tube testing process and SOPs;

alternate reagents would require full method revalidation and correlation prior to patient use, causing unacceptable risk and delay in transfusion support.

2. Preserve established quality controls (QC kit, IgG-sensitized cells, and C3-coated cells) and performance characteristics specific to Alba reagent panels as used by the facility.

3. Ensure compliance with 21 CFR Part 660 Subpart D (Reagent Red Blood Cells) and accreditation standards (AABB, CLIA, CAP, FDA) under the facility’s validated method and documentation set.

3. SCOPE

1. The Contractor shall provide ONLY the Alba brand reagents listed in Deliverables; no substitutes or “or equal” items are permitted.

2. Products shall be supplied directly by Alba or an Alba‑authorized distributor; the offeror shall furnish current written authorization from Alba with its offer and upon request during performance.

3. Reagents will be shipped on a standing order schedule.

4. All products shall meet all salient characteristics defined in this section.

5. All reagents shall meet manufacturers and VA specifications.

6. The Contractor shall perform to the standards in this contract.

4. SALIENT CHARACTERISTICS

1. All the reagents shall be prepackaged and ready for use.

2. All reagent red blood cells shall be in compliance with the Code of Federal regulations- 21 CFR Part 660 Subpart D-Reagent Red Blood Cells.

3. These items shall be of the highest quality, sensitivity and tested to assure precision and accuracy.

4. Expiration dates shall be clearly marked on all reagent containers.

5. Unexpected changes in methodology/technology shall be at the expense of the contractor.

6. The contractor shall state the open date stability for the reagents for both room temperature and refrigeration.

7. The contractor shall package reagents in such a manner as to ensure the integrity of the reagents during transport.

8. The contractor shall explain their policy on replacement of unsuitable or damaged products or products shipped in error.

9. The contractor shall supply all package inserts, Safety Data Sheets, and other relevant information for their proposed reagents.

10. The contractor shall inform each COR of any reagent recalls or bulletins due to product unavailability due to manufacturing issues.

11. Alert/Notifications of any delays in shipment as well as any or all technical advisory/recall/alerts, prior to or simultaneously with filed alerts shall be forwarded to each contracting officer.

12. The contractor shall provide their plan for product availability if supplies/products become scarce or unavailable.

13. Vendor shall provide a VA acceptable itemized bill for all items shipped for payment with each shipment.

14. Payments shall be made in arrears.

15. Reagent identity, formulation, labeling, and package inserts shall match Alba OEM documentation for the specific reagent lots supplied.

16. Open‑date stability claims (room temperature and refrigerated) shall be those stated in Alba package inserts; any deviation is non‑conforming.

17. IgG‑sensitized cells and C3‑coated cells shall be Alba brand and traceable to Alba lot records for QC.

18. Antibody screening (3‑cell panel) and identification (10‑cell panel) shall be Alba brand reagent red blood cells manufactured and documented per 21 CFR Part 660 Subpart D.

5. DELIVERY & SHIPPING

Delivery of reagents will be on as standing order basis.

1. Location:

G.V (Sonny) Montgomery VAMC

1500 E Woodrow Wilson Ave., Jackson, MS

Basement, Laboratory C-19

Attn: Blood Bank

Contractor shall deliver all reagents acceptably packaged to location listed. Contractor shall ship reagents on a standing basis to location as follows:

G.V (Sonny) Montgomery VAMC

Reagent Quantity Frequency Total

A1 Cells 2 Every 4 weeks 28

A2 Cells 2 Every 4 weeks 28

B Cells 2 Every 4 weeks 28

Antibody Screening Cells (3 Panel)

2 Every 4 weeks 28

Antibody Identification Cells (10 Panel)

1 Every 4 weeks 13

IgG Sensitized Cells 4 Every 4 weeks 52

C3 Cells 2 Every 4 weeks 28

QC Kit 1 Every 4 weeks 13

6. INSPECTION AND ACCEPTANCE:

1. The COR shall ensure all items are satisfactory prior to acceptance. Disputes shall be resolved by the Contracting Officer.

2. The designated COR’s or Point of Contact will be given after contract award.

3. The COR shall reject any shipment that includes non‑Alba brand reagents, mixed manufacturers, or relabeled products. Replacement with Alba brand only shall be at Contractor expense.

7. DELIVERY/STORAGE REQUIREMENTS

1. Deliver reagent materials to job in manufacturer's original sealed containers with brand name marked thereon.

2. Package to prevent damage or deterioration during shipment, handling, and storage.

3. Deliver specified items only when the site is ready to proceed.

4. Store products in dry condition inside enclosed facilities.

5. Delivery dates will be communicated when products orders are placed.

6. Delivery will be coordinated through the Blood Bank Supervisor for the G.V (Sonny) Montgomery VAMC and the Blood Bank Supervisor for VHSO.

7. Shipments shall originate from Alba or an Alba‑authorized distributor; substitution shipments from any other manufacturer or re‑labeler are prohibited.

8. Any supply chain changes affecting brand, labeling, or inserts require prior written approval from the Contracting Officer.

9. Installation is not required.

10. DELIVERABLES:

Reagent Type

A1 Cells Tube

A2 Cells Tube

B Cells Tube

Antibody Screening cells-3 Panel Cell Tube

Antibody Identification Cells -10 Panel Cell Tube

IgG sensitized Cells Tube

QC Kit Tube

C3 Coated Cells Tube

8. SECURITY REQUIREMENTS

GENERAL

Contractors, contractor personnel, subcontractors, and subcontractor personnel shall be subject to the same Federal laws, regulations, standards, and VA Directives and Handbooks as VA and VA personnel regarding information and information system security. Recall/alert notifications must reference Alba OEM lot numbers; Contractor shall demonstrate capability to trace, and quarantine affected Alba lots upon notice.

8a. SECURITY CLAUSE: "A&A requirements do not apply--Security Accreditation Package is not required".

NARA Records Management Language Clause:

The following standard items relate to records generated in executing the contract and should be included in a typical contract:

1. Contractor shall comply with all applicable records management laws and regulations, as well as National Archives and Records Administration (NARA) records policies, including but not limited to the Federal Records Act (44 U.S.C. chs. 21, 29, 31, 33), NARA regulations at 36 CFR Chapter XII

2. Subchapter B, and those policies associated with the safeguarding of records covered by the Privacy Act of 1974 (5 U.S.C. 552a). These policies include the preservation of all records, regardless of form or characteristics, mode of transmission, or state of completion.

3. In accordance with 36 CFR 1222.32, all data created for Government use and delivered to, or falling under the legal control of, the Government are Federal records subject to the provisions of 44 U.S.C. chapters 21, 29, 31, and 33, the Freedom of Information Act (FOIA) (5 U.S.C. 552), as amended, and the Privacy Act of 1974 (5 U.S.C. 552a), as amended and must be managed and scheduled for disposition only as permitted by statute or regulation.

4. In accordance with 36 CFR 1222.32, Contractor shall maintain all records created for

Government use or created while performing the contract and/or delivered to, or under the legal control of the Government and must be managed in accordance with Federal law. Electronic records and associated metadata must be accompanied by sufficient technical documentation to permit understanding and use of the records and data.

5. G.V. Sonny Montgomery VAMC (GVSMVAMC), Veterans Health Care System of the

Ozarks (VHSO) and its contractors are responsible for preventing the alienation or unauthorized destruction of records, including all forms of mutilation. Records may not be removed from the legal custody of [Agency] or destroyed except for in accordance with the provisions of the agency records schedules and with the written concurrence of the Head of the Contracting Activity. Willful and unlawful destruction, damage or alienation of Federal records is subject to the fines and penalties imposed by 18 U.S.C.

2701. In the event of any unlawful or accidental removal, defacing, alteration, or destruction of records, Contractor must report to [Agency]. The agency must report promptly to NARA in accordance with 36 CFR 1230.

6. The Contractor shall immediately notify the appropriate Contracting Officer upon discovery of any inadvertent or unauthorized disclosures of information, data, documentary materials, records or equipment. Disclosure of non-public information is limited to authorized personnel with a need-toknow as described in the [contract vehicle]. The Contractor shall ensure that the appropriate personnel, administrative, technical, and physical safeguards are established to ensure the security and confidentiality of this information, data, documentary material, records and/or equipment is properly protected. The Contractor shall not remove material from Government facilities or systems, or facilities or systems operated or maintained on the Government’s behalf, without the express written permission of the Head of the Contracting

Activity. Contractor personnel shall sign VA Form 10-0708 “Employee Clearance from Indebtedness” before resigning or termination from Contractor working for GVSMVAMC, VHSO and Facility Records Officer must sign form. A copy of completed signed VA Form 10-0708 (Contractor personnel and Facility Records Officer signatures) shall be place in each competency folder. When information, data, documentary material, records and/or equipment is no longer required, it shall be returned to [Agency] control or the Contractor must hold it until otherwise directed. Items returned to the Government shall be hand carried, mailed, emailed, or securely electronically transmitted to the Contracting Officer or address prescribed in the [contract vehicle]. Destruction of records is EXPRESSLY PROHIBITED unless in accordance with Paragraph

(4).

7. The Contractor is required to obtain the Contracting Officer's approval prior to engaging in any contractual relationship (sub-contractor) in support of this contract requiring the disclosure of information, documentary material and/or records generated under, or relating to, contracts. The Contractor (and any sub-contractor) is required to abide by Government and [Agency] guidance for protecting sensitive, proprietary information, classified, and controlled unclassified information.

8. The Contractor shall only use Government IT equipment for purposes specifically tied to or authorized by the contract and in accordance with GVSMVAMC and VHSO policy.

9. The Contractor shall not create or maintain any records containing any non-public

GVSMVAMC information that are not specifically tied to or authorized by the contract.

10. The Contractor shall not retain, use, sell, or disseminate copies of any deliverable that contains information covered by the Privacy Act of 1974 or that which is generally protected from public disclosure by an exemption to the Freedom of Information Act.

11. The GVSMVAMC and VHSO owns the rights to all data and records produced as part of this contract. All deliverables under the contract are the property of the U.S. Government for which GVSMVAC and VHSO shall have unlimited rights to use, dispose of, or disclose such data contained

12. therein as it determines to be in the public interest. Any Contractor rights in the data or deliverables must be identified as required by FAR 52.227-11 through FAR 52.227-20.

13. Training. All Contractor employees assigned to this contract who create, work with, or otherwise handle records are required to take [Agency]-provided records management training. The Contractor is responsible for confirming training has been completed according to agency policies, including initial training and any annual or refresher training. TMS (Talent Management System) course VA 4192704: “Records Management for Everyone” [Note: To the extent an agency requires contractors to complete records management training, the agency must provide the training to the contractor.]

8b. Policy and Regulations:

Flow-down of requirements to subcontractors:

1. The Contractor shall incorporate the substance of this clause, its terms and requirements including this paragraph, in all subcontracts under this [contract vehicle], and require written subcontractor acknowledgment of same.

2. Violation by a subcontractor of any provision set forth in this clause will be attributed to the Contractor.

3. The Contractor is required to meet VHA performance and quality criteria and standards including, but not limited to, access, customer satisfaction, prevention index, chronic disease index and clinical guidelines. Performance and quality standards may change during the contract. New or revised quality/performance criteria or standards will be provided to the Contractor before implementation date and throughout the life of the contract through unilateral or bi-lateral modifications, as applicable. Copies of current VA and VHA publications can be located at http://www.va.gov/vhapublications/ or at http://www.va.gov/vapubs/. Compliance with mandated performance is required as a condition of this contract. Contractor shall comply with all relevant VA policies and procedures, including those related to quality, access, patient safety, and performance, including, but not limited to the policies and regulations set forth by the following regulating agencies: Joint Commission (TJC), Clinical

Laboratory Improvement Amendments (CLIA), College of American Pathologists (CA), Federal Drug Administration (FDA), Centers for Disease Control (CDC), and Association for the Advancement of Blood & Biotherapies (AABB).

Contractor Date

Company Name

SECTION C - CONTRACT CLAUSES

C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES (OCT 2025) (DEVIATION)

(a) Definitions. The clause at Federal Acquisition Regulation (FAR) 52.202-1, Definitions, is incorporated by reference.

(b) Inspection/Acceptance. The Contractor shall only tender for acceptance those items that conform to the requirements of this contract. The Government reserves the right to inspect or test any supplies or services that have been tendered for acceptance. The Government may require repair or replacement of nonconforming supplies or reperformance of nonconforming services at no increase in contract price. If repair/replacement or reperformance will not correct the defects or is not possible, the Government may seek an equitable price reduction or adequate consideration for acceptance of nonconforming supplies or services. The Government must exercise its post acceptance rights—

(1) Within a reasonable time after the defect was discovered or should have been discovered;

and

(2) Before any substantial change occurs in the condition of the item, unless the change is due to the defect in the item.

(c) Assignment. The Contractor or its assignee may assign its rights to receive payment due as a result of performance of this contract to a bank, trust company, or other financing institution, including any Federal lending agency in accordance with the Assignment of Claims Act (31 U.S.C. 3727). However, when a third party makes payment (e.g., use of the Governmentwide commercial purchase card), the Contractor may not assign its rights to receive payment under this contract.

(d) Changes. Changes in the terms and conditions of this contract may be made only by written agreement of the parties.

(e) Disputes. This contract is subject to 41 U.S.C. chapter 71, Contract Disputes. Failure of the parties to this contract to reach agreement on any request for equitable adjustment, claim, appeal or action arising under or relating to this contract shall be a dispute to be resolved in accordance with the clause FAR 52.233-1, Disputes, which is incorporated in this contract by reference. The Contractor shall proceed diligently with performance of this contract, pending final resolution of any dispute arising under the contract.

(f) Excusable delays. The Contractor shall be liable for default unless nonperformance is caused by an occurrence beyond the reasonable control of the Contractor and without its fault or negligence. Examples of occurrences include acts of God or the public enemy, acts of the Government in either its sovereign or contractual capacity, fires, floods, epidemics, quarantine restrictions, strikes, unusually severe weather, and delays of common carriers. When an excusable delay occurs, the Contractor shall—

(1) Notify the Contracting Officer in writing as soon as possible;

(2) Remedy the delay as quickly as possible; and

(3) Notify the Contracting Officer when the occurrence is over.

(g) Invoice. The Government will handle invoices according to the Prompt Payment Act (31 U.S.C. 3903) and 5 CFR part 1315. The Contractor shall submit invoices to the address designated in the contract to receive invoices. An invoice must include the information required by 5 CFR part 1315.9(b).

(h) Patent indemnity. The Contractor shall indemnify the Government and its officers, employees, and agents against liability, including costs, for actual or alleged direct or contributory infringement of, or inducement to infringe, any United States or foreign patent, trademark, or copyright, arising out of the performance of this contract, provided the Contractor is reasonably notified of such claims and proceedings.

(i) Payment—

(1) Items accepted. Payment shall be made for items accepted by the Government that have been delivered to the delivery destinations set forth in this contract.

(2) Prompt payment. The Government will make payment in accordance with the Prompt Payment Act (31 U.S.C. 3903) and prompt payment regulations at 5 CFR part 1315.

(3) Discount. In connection with any discount offered for early payment, time shall be computed from the date of the invoice. For the purpose of computing the discount earned, payment shall be considered to have been made on the date that appears on the payment check or the specified payment date if an electronic funds transfer payment is made.

(4) Overpayments. If the Contractor becomes aware of a duplicate contract financing or invoice payment or that the Government has otherwise overpaid on a contract financing or invoice payment, the Contractor shall—

(i) Remit the overpayment amount to the payment office cited in the contract along with a description of the overpayment including the—

(A) Circumstances of the overpayment (e.g., duplicate payment, erroneous payment, liquidation errors, date(s) of overpayment);

(B) Affected contract number and delivery order number, if applicable;

(C) Affected line item or subline item, if applicable;

(D) Contractor point of contact; and

(ii) Provide a copy of the remittance and supporting documentation to the Contracting Officer.

(5) Interest.

(i) All amounts that become payable by the Contractor to the Government under this contract shall bear simple interest from the date due until paid unless paid within 30 days of becoming due. The interest rate shall be the interest rate established by the Secretary of the

Treasury as provided in 41 U.S.C. 7109, which is applicable to the period in which the amount becomes due, as provided in (i)(6)(v) of this clause, and then at the rate applicable for each six-month period as fixed by the Secretary until the amount is paid.

(ii) The Government may issue a demand for payment to the Contractor upon finding a debt is due under the contract.

(iii) Final decisions. The Contracting Officer will issue a final decision as required by FAR part 33 if—

(A) The Contracting Officer and the Contractor are unable to reach agreement on the existence or amount of a debt within 30 days;

(B) The Contractor fails to liquidate a debt previously demanded by the Contracting Officer within the timeline specified in the demand for payment unless the amounts were not repaid because the Contractor has requested an installment payment agreement; or

(C) The Contractor requests a deferment of collection on a debt previously demanded by the Contracting Officer (see FAR part 32).

(iv) If a demand for payment was previously issued for the debt, the demand for payment included in the final decision shall identify the same due date as the original demand for payment.

(v) Amounts shall be due at the earliest of the following dates:

(A) The date fixed under this contract.

(B) The date of the first written demand for payment, including any demand for payment resulting from a termination for cause.

(vi) The interest charge shall be computed for the actual number of calendar days involved beginning on the due date and ending on-

(A) The date on which the designated office receives payment from the Contractor;

(B) The date of issuance of a Government check to the Contractor from which an amount otherwise payable has been withheld as a credit against the contract debt; or

(C) The date on which an amount withheld and applied to the contract debt would otherwise have become payable to the Contractor.

(vii) The interest charge made under this clause may be reduced under the procedures for interest credits prescribed in FAR part 32 in effect on the date of this contract.

(j) Risk of loss. Unless the contract specifically provides otherwise, risk of loss or damage to the supplies provided under this contract shall remain with the Contractor until, and shall pass to the Government upon—

(1) Delivery of the supplies to a carrier, if transportation is f.o.b. origin; or

(2) Delivery of the supplies to the Government at the destination specified in the contract, if transportation is f.o.b. destination.

(k) Taxes. The contract price includes all applicable Federal, State, and local taxes and duties.

(l) Termination for the Government's convenience. The Government reserves the right to terminate this contract, or any part hereof, for its sole convenience. In the event of such termination, the Contractor shall immediately stop all work and shall immediately cause any and all of its suppliers and subcontractors to cease work. Subject to the terms of this contract, the Contractor shall be paid a percentage of the contract price reflecting the percentage of the work performed prior to the notice of termination, plus reasonable charges the Contractor can demonstrate to the satisfaction of the Government using its standard record keeping system, have resulted from the termination. The Contractor shall not be required to comply with the cost accounting standards or contract cost principles for this purpose. This paragraph does not give the Government any right to audit the Contractor's records. The Contractor shall not be paid for any work performed or costs incurred which reasonably could have been avoided.

(m) Termination for cause. The Government may terminate this contract, or any part hereof, for cause in the event of any default by the Contractor, or if the Contractor fails to comply with any contract terms and conditions, or fails to provide the Government, upon request, with adequate assurances of future performance. The Government will send a cure notice to the Contractor, unless the reason for the termination is late delivery. In the event of termination for cause, the Government shall not be liable to the Contractor for any amount for supplies or services not accepted, and the Contractor shall be liable to the Government for any and all rights and remedies provided by law. If it is determined that the Government improperly terminated this contract for default, such termination shall be deemed a termination for convenience.

(n) Title. Unless specified elsewhere in this contract, title to items furnished under this contract shall pass to the Government upon acceptance, regardless of when or where the Government takes physical possession.

(o) Warranty. The Contractor warrants and implies that the items delivered under this contract are merchantable and fit for use for the particular purpose described in this contract.

(p) Limitation of liability. Except as otherwise provided by an express warranty, the Contractor will not be liable to the Government for consequential damages resulting from any defect or deficiencies in accepted items.

(q) Compliance with laws unique to Government contracts. The Contractor agrees to comply with 31 U.S.C. 1352 relating to limitations on the use of appropriated funds to influence certain Federal contracts; 40 U.S.C. chapter 37, Contract Work Hours and Safety Standards; 41 U.S.C.

chapter 87, Kickbacks; 49 U.S.C. 40118, Government-financed air transportation; and 41 U.S.C.

chapter 21 relating to procurement integrity.

(r) Order of precedence. Any inconsistencies in this solicitation or contract shall be resolved by giving precedence in the following order:

(1) The schedule of supplies/services.

(2) The Disputes, Payments, Invoice,…